Antisense Oligonucleotide [EPC]

11948 reported adverse events

Drugs of this class: CASIMERSEN EPLONTERSEN ETEPLIRSEN GOLODIRSEN NUSINERSEN TOFERSEN

These side effects are most commonly reported by patients taking drugs of the Antisense Oligonucleotide [EPC] class:

# Side effect Count
0 PRODUCT DOSE OMISSION ISSUE 1133
1 NO ADVERSE EVENT 825
2 HEADACHE 627
3 PYREXIA 586
4 POST LUMBAR PUNCTURE SYNDROME 524
5 PNEUMONIA 463
6 INTENTIONAL DOSE OMISSION 399
7 VOMITING 394
8 PROCEDURAL PAIN 392
9 POOR VENOUS ACCESS 389
See all common reactions for Antisense Oligonucleotide [EPC]

Drugs of the Antisense Oligonucleotide [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POST LUMBAR PUNCTURE SYNDROME 524 0.5038
1 SPINAL MUSCULAR ATROPHY 107 0.3963
2 PROCEDURAL VOMITING 48 0.0738
3 PROCEDURAL NAUSEA 45 0.0559
4 PROCEDURAL ANXIETY 30 0.0442
5 CEREBROSPINAL FLUID LEAKAGE 79 0.0427
6 SCOLIOSIS 248 0.0400
7 EXPOSURE TO SARS-COV-2 65 0.0382
8 POOR VENOUS ACCESS 389 0.0376
9 RHINOVIRUS INFECTION 110 0.0282
See all enriched reactions for Antisense Oligonucleotide [EPC]